Share on

North America Microbial Identification Market Research Report - Segmented By Method, Application, Product, End User & Country (U.S, Canada & Rest of North America) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2023 to 2028)

Published: March, 2023
ID: 7900
Pages: 145
Formats: report pdf report excel report power bi report ppt

North America Microbial Identification Market Size & Growth (2023 to 2028):

As per the research report, the North America Microbial identification market size is expected to reach USD 0.63 billion by 2028 from USD 0.45 billion which is valued in 2023, growing at a CAGR of 6.62% during the forecast period 2023 to 2028.

The rising frequency of infectious diseases and global food safety concerns will drive the North American microbial identification market. Microbial detection is widely used by governments, private institutes, agricultural producers, water treatment facilities, alcohol producers, and other research laboratories.

Furthermore, the North American microbial identification market is expected to be driven by government efforts and rising healthcare spending in the future years. Rapid advances in microbiology have aided the growth of the North American microbial identification industry. In addition, the collaboration between pharmacy and medical intervention fosters regional market expansion in regional markets.

Continued technical developments in the precise precision and speed of microbial identification equipment, an increase in the number of diseases caused by hazardous bacteria, and tight food safety standards are driving the North American microbiological identification market. For the past few years, several scientific breakthroughs based on basic molecular processes have been offered.

These technologies, particularly peptide nucleic acid fluorescence in situ hybridization (PNA-FISH) and tailored real-time PCR assays like GeneXpert, aid in microbial identification and potentially save money. Furthermore, rising government and private-sector investments are expected to boost the market for microbial identification.

Automated microbiological detection devices are more expensive and have more advanced features and capabilities, such as a MALDI-TOF-based device. In addition, the consumables required in identification techniques and the labor involved are frequently expensive. Recent quick trials have also necessitated significantly more cash than traditional culture approaches.

Because of their tiny budgets, the average cost of tools, media, and labor is disproportionately high for specific end-users; academic research facilities cannot afford such systems. In addition, the employment of microbiological detection technologies generally necessitates skilled specialists, and the microbial sector's development is hampered by a scarcity of trained professionals. Microbial detection methods like gene sequencing, for example, provide speedy results but cost money and require specialized workers, limiting their application.

This research report on the North America Microbial Identification Market has been segmented and sub-segmented into the following categories.

By Method:

  • Genotypic
  • Proteomics-based
  • Phenotypic

By Application:

  • F&B
  • Diagnostic
  • Pharmaceutical
  • Environmental

By Product:

  • Identification Services
  • Consumables
  • Instruments

By End User:

  • Food Manufacturing Industries
  • Pharmaceutical Companies
  • Hospitals
  • Diagnostic Centres
  • Others

By Country:

  • U.S
  • Canada
  • Rest of North America

Geographically, North America currently leads the industry in microbial identification and is expected to continue to do so for some time. A well-established healthcare business, growing healthcare spending, and favorable reimbursement rules drive regional market expansion.

The U.S microbial identification market dominated the market globally, and this trend is expected to continue in the following years. Clinical microbiology technologies have a high penetration rate in the United States, and the industry is growing thanks to multiple distribution channels.

Furthermore, manufacturers and industry players prioritize research and development operations, which are likely to give lucrative market growth prospects. Again, a growing senior population increased awareness of blood-related illnesses, and increased healthcare drives market expansion.

The Canadian microbial identification market is expected to grow steadily during the forecast period due to the rising incidence of infectious diseases, and supportive government policies, increased investments, and government funding contribute to market expansion.

KEY MARKET PLAYERS

Companies playing a dominant role in the North America Microbial Identification Market profiled in this report are Charles River Laboratories International Inc, Trivitron Healthcare, Thermo Fisher Scientific Inc., Bruker Corporation, VWR Corporation, Dickinson & Company, Merck KGaA, IEH Laboratories & Consulting Group, Shimadzu Corporation.,

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample